openPR Logo
Press release

Global Anti-Viral Drug Therapy Market 2021 - By Top Players, Latest Trends, Demand Analysis and Forecast to 2030

10-18-2021 12:34 PM CET | Health & Medicine

Press release from: The Business research company

Anti-Viral Drug Therapy Market

Anti-Viral Drug Therapy Market

The Business Research Company offers “Antivirals Global Market Report 2021 - By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), By Type (Branded, Generic), COVID-19 Implications And Growth" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The anti-viral drug therapy market report describes and explains the global anti-viral drug therapy market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

Place A Direct Purchase Order Of The Report Here
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2437

The anti-viral drug therapy market consists of sales of anti-viral drugs used for the treatment of viral infections, such as human immunodeficiency virus (HIV), hepatitis, influenza and novel coronavirus. Antiviral drugs do not kill their target pathogen, instead they inhibit the development of those viruses. The anti-viral drugs establishments are primarily engaged in the manufacturing of DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others.

The global antivirals market is expected to decline from $62.62 billion in 2020 to $52.13 billion in 2021 at a compound annual growth rate (CAGR) of -16.8%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $67.66 billion in 2025 at a CAGR of 6.7%.

Request For The Sample Of The Anti-Viral Drug Therapy Market Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

Some of the major players of the anti-viral drug therapy market are AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd, AstraZeneca plc., Aurobindo Pharma, Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi, Regeneron Pharmaceuticals, Inc., Inovio Pharmaceuticals, Inc., Novavax, Inc., BioCryst Pharmaceuticals, Inc.

The countries covered in the global anti-viral drug therapy market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global anti-viral drug therapy market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global anti-viral drug therapy market is segmented -
1) By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others.
2) By Application: HIV, Hepatitis, Herpes, Influenza, Others.
3) By Type: Branded, Generic

Read More On The Global Anti-Viral Drug Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Anti-Viral Drug Therapy Market Characteristics
3. Anti-Viral Drug Therapy Market Trends And Strategies
4. Impact Of Covid-19 On Anti-Viral Drug Therapy
5. Anti-Viral Drug Therapy Market Size And Growth
.....
26. Africa Anti-Viral Drug Therapy Market
27. Anti-Viral Drug Therapy Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Anti-Viral Drug Therapy Market
29. Anti-Viral Drug Therapy Market Future Outlook And Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Anti-Viral Drug Therapy Market 2021 - By Top Players, Latest Trends, Demand Analysis and Forecast to 2030 here

News-ID: 2431163 • Views:

More Releases from The Business research company

Mega Data Center Market Research Report 2024 - 2033 | Insights, Analysis, and Ke …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Mega Data Center Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The mega data center market size has grown strongly in recent
Eyelid Scrub Market: Segments Overview, Trends, and Comprehensive Report 2024-2033
Eyelid Scrub Market: Segments Overview, Trends, and Comprehensive Report 2024-20 …
"The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033. The Business Research Company presents an extensive market research report on the Eyelid Scrub Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,
Text-To-Speech Market Forecast Report | Analysis, Insights, and Size Opportunities 2024-2033
Text-To-Speech Market Forecast Report | Analysis, Insights, and Size Opportuniti …
"The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033. The Business Research Company presents an extensive market research report on the Text-To-Speech Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing
Self-Administered Parenteral Market: Key Trends and Competitor Assessment 2024-2033 - Evaluating Market Landscape
Self-Administered Parenteral Market: Key Trends and Competitor Assessment 2024-2 …
"The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033. The Business Research Company presents an extensive market research report on the Self-Administered Parenteral Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug